Related Experiment Video
Updated: May 27, 2026
Microbiological Rapid On-Site Evaluation for Pulmonary Infectious Diseases
Published on: March 1, 2024
[When to ask a microbiological diagnostic test in pneumonia and how to interpret the results]
1Service des maladies infectieuses, centre hospitalier de la région d'Annecy, 74374 Pringy Cedex. jgaillat@ch-annecy.fr
Abstract:
Pneumonia is a leading cause of death in adults in the industrialised countries and in the rest of the world in infants. Most of the time the pathogens stay unkown and the current recommendations for the treatment of pneumonia are mainly based on a severity score to adapt the treatement to the risk. Nonethless new pathogens have recently been identified, coronavirus for SRASS, H5N1 for avian Flu, N1N1 for pandemic Flu, 35 years after the identification of Legionella pneumophila. These exemples stress the necessity to do and continue to identify pathogens in these clinical situations. Those last years new diagnostic tests have been elaborated: antigen detection in urines or in nasopharyngeal samples, molecular methods allowing to look at one or several pathogens at the same time on a single sample (Multiplex) with an increased sensitivity with regard to the more classical methods. Indirect methods have been developed to quantify inflammation in correlation with a bacterial or not infection. All these tests contribute to a better understanding but can and/or could be used in new algorithms to treat patients with pneumonia.
Insights
Identifying pneumonia pathogens is crucial for effective treatment. Advances in diagnostic tests, including antigen detection and multiplex molecular methods, improve pathogen identification and inform new treatment strategies.
Area of Science:
- Medical Microbiology
- Infectious Diseases
- Clinical Diagnostics
Context:
- Pneumonia remains a significant cause of mortality globally, particularly in infants and adults.
- Current treatment relies heavily on severity scores due to frequently unidentified pathogens.
- Recent discoveries of novel pathogens like coronaviruses and influenza strains highlight the need for continuous identification.
Purpose:
- To underscore the importance of ongoing pathogen identification in pneumonia cases.
- To review advancements in diagnostic methodologies for pneumonia.
- To explore the potential integration of new diagnostic tests into clinical algorithms.
Summary:
- New diagnostic tools, such as antigen detection and multiplex molecular assays, offer increased sensitivity and the ability to detect multiple pathogens simultaneously.
- Indirect methods are being developed to quantify inflammation, aiding in the differentiation of bacterial and non-bacterial infections.
- These diagnostic innovations contribute to a better understanding of pneumonia etiology.
Impact:
- Improved pathogen identification can lead to more targeted and effective pneumonia treatments.
- The integration of advanced diagnostics into clinical practice may enhance patient outcomes and reduce mortality.
- These advancements support the development of novel treatment algorithms for pneumonia management.
Related Concept Videos
01:30Pneumonia III: Complications and Assessment
01:26Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
01:20Sputum Studies II: Culture and Sensitivity
Sputum culture and sensitivity is a medical procedure used to diagnose bacterial infections in the respiratory tract and select the most appropriate antibiotics for treatment. This process involves analyzing sputum samples of thick and opaque secretions produced in the lungs and airways. These samples are collected from patients and then sent to the laboratory for analysis.
The test can identify various pathogens responsible for respiratory infections, including Streptococcus,...
01:14Atypical Pneumonia
01:29Pneumonia II: Pathophysiology
01:28Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include: